San Antonio Breast Cancer Symposium - SABCS
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to San Antonio Breast Cancer Symposium - SABCS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Data sheet
San Antonio Breast Cancer Symposium - SABCS – Event Attendee & Buyer Profile Analysis
Event date: December 8–11, 2026
Location: San Antonio, Texas, United States
Event status: Upcoming
Research date: July 2, 2026
Event Overview
| Event Name | San Antonio Breast Cancer Symposium (SABCS) 2026 |
| Event Date | December 8–11, 2026 |
| Event Status | Upcoming |
| Venue | Not publicly specified in the provided official website content |
| City | San Antonio |
| State / Region | Texas |
| Country | United States |
| Organizer | UT Health San Antonio / SABCS organizing team |
| Official Event Website | sabcs.org |
| Event Type | Scientific symposium, medical conference, research meeting, exhibition/support opportunities |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research, Education & Training |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | 11,000+ attendees (officially stated on the event website) |
| Attendance Data Reliability | Confirmed by organizer on official website |
| Main Purpose of Event | To present practice-changing advances in basic, translational, and clinical breast cancer research, facilitate scientific exchange, and connect the global breast cancer community. |
About the Event
The San Antonio Breast Cancer Symposium (SABCS) is positioned as the world’s largest breast cancer research meeting. It brings together leading scientists, clinicians, advocates, and industry organizations to share breakthroughs across basic, translational, and clinical research, with a direct focus on improving patient care and advancing oncology practice.
The symposium is highly relevant for B2B outreach because it attracts a concentrated audience of research institutions, healthcare organizations, pharma and biotech stakeholders, and supporting solution providers. For suppliers serving oncology, life sciences, clinical research, diagnostics, healthcare services, or medical education, SABCS offers strong visibility into active decision-makers, innovation leaders, and partnership opportunities across the breast cancer ecosystem.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical researchers and principal investigators | Universities, cancer centers, research hospitals | Influence on trials, protocols, research tools, and collaborations | High for research instruments, trial services, publications, and data solutions |
| Oncologists and specialty physicians | Hospitals, academic medical centers, cancer clinics | Clinical decision influence and treatment adoption | High for diagnostics, therapeutics, devices, and continuing education |
| Research institute leadership | Cancer institutes, academic health systems | Budget and partnership oversight | High for strategic partnerships, research platforms, and sponsorships |
| Clinical trial operations teams | Hospitals, CROs, sponsor companies | Vendor selection for trial execution and management | High for CRO services, eClinical tech, patient recruitment, and compliance tools |
| Pharma and biotech R&D teams | Drug developers, life sciences companies | Product strategy, evidence generation, and external partnerships | High for discovery tools, biomarker platforms, and clinical trial support |
| Medical affairs and market access teams | Pharma, biotech, diagnostics firms | Scientific communication and evidence generation | High for scientific services, KOL engagement, and congress support |
| Pathology and diagnostics leaders | Labs, hospitals, diagnostic providers | Test adoption and technology evaluation | High for lab instruments, molecular diagnostics, AI pathology, and sample handling |
| Patient advocacy leaders | Advocacy groups, nonprofit organizations | Program influence, patient outreach, education | Medium to high for education platforms, patient support tools, and nonprofit partnerships |
| Exhibitors and sponsors | Industry and nonprofit organizations | Decision-makers for activation, lead generation, and brand exposure | High for event services, exhibit solutions, marketing, and sponsorship sales |
| Early-career scientists and fellows | Universities, training hospitals, research labs | Future purchasing influence and collaboration potential | Medium for education, lab tools, career programs, and research software |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: San Antonio | Local healthcare providers, universities, sponsors, event partners | Medium | Local attendance supports logistics, hospitality, and on-site event operations |
| Host state / region: Texas | Texas medical centers, cancer hospitals, universities, life sciences firms | High | Strong regional concentration from major Texas healthcare and research hubs |
| Nearby business hubs | Houston, Dallas-Fort Worth, Austin, South Texas corridor | High | These metros contain major hospitals, research centers, and pharma/service providers |
| National reach | U.S. academic centers, oncology networks, pharma, CROs, nonprofits | Very High | The event is a major North American oncology meeting with strong national attendance potential |
| International reach | Global breast cancer researchers, clinicians, and industry organizations | Very High | Official website states participation from 104 countries, confirming broad international reach |
| Key countries / regions | United States, Canada, Europe, Latin America, Asia-Pacific | High | Likely aligned with global oncology research and pharma collaboration corridors |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The organizer states the symposium attracts a global breast cancer community and participation from 104 countries. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| The University of Texas MD Anderson Cancer Center | Cancer center / healthcare buyer | Major oncology research and treatment institution; strong fit for clinical research, diagnostics, and education solutions | mdanderson.org | Procurement Director, Research Director, Clinical Trial Manager, Oncology Program Director | Strong Market Fit, Attendance Not Confirmed |
| Memorial Sloan Kettering Cancer Center | Cancer center / healthcare buyer | High-value oncology buyer for research platforms, lab technologies, and trial services | mskcc.org | Director of Clinical Research, Lab Operations Director, Procurement Manager, Medical Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| Dana-Farber Cancer Institute | Cancer institute / research buyer | Key academic cancer center with strong demand for research and clinical solutions | dana-farber.org | Director of Research Operations, Strategic Sourcing Manager, Oncology Department Head | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Healthcare system buyer | Large health system with advanced oncology, pathology, and research purchasing needs | mayoclinic.org | Supply Chain Director, Oncology Service Line Director, Clinical Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Healthcare system buyer | Large academic medical center with significant oncology and research procurement activity | clevelandclinic.org | Director of Procurement, Oncology Operations Director, Research Administration Leader | Strong Market Fit, Attendance Not Confirmed |
| City of Hope | Cancer center / research buyer | Oncology-focused institution with research, trial, and patient support priorities | cityofhope.org | Clinical Trial Director, Procurement Manager, Research Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic healthcare buyer | Research-intensive medical system relevant to oncology clinical trials and academic partnerships | hopkinsmedicine.org | Research Director, Hospital Procurement Lead, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| UCSF Health | Academic medical center buyer | Advanced oncology and translational research environment | ucsfhealth.org | Director of Research, Clinical Procurement Manager, Oncology Program Administrator | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma buyer / sponsor | Breast cancer drug developer with strong congress and medical affairs relevance | astrazeneca.com | Medical Affairs Director, Oncology Brand Lead, Congress Manager | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharma buyer / sponsor | Major oncology stakeholder with scientific and commercial interest in breast cancer meetings | pfizer.com | Medical Affairs Lead, Oncology Director, Event Marketing Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Scientific Officer | Executive | C-level | Owns scientific strategy, partnership direction, and major program investments |
| 2 | Director of Clinical Research / Clinical Trial Operations | Clinical Research | Director | Primary buyer for trial tools, CRO services, and study support vendors |
| 3 | Head of Oncology / Oncology Program Director | Clinical Operations | Director / VP | Influences treatment pathways, services, and technology adoption |
| 4 | Procurement Director / Strategic Sourcing Manager | Procurement / Supply Chain | Director / Manager | Manages vendor evaluation, contracting, and purchasing across research and healthcare functions |
| 5 | Medical Affairs Director / Manager | Medical Affairs | Manager / Director | Uses congresses for scientific exchange, evidence generation, and KOL engagement |
| 6 | R&D Director / Translational Research Lead | Research & Development | Director / Senior Manager | Evaluates platforms, biomarkers, and research partnerships |
| 7 | Lab Director / Pathology Director | Laboratory / Diagnostics | Director | Relevant for assay, pathology, and diagnostic technology purchases |
| 8 | Research Administrator / Grants Manager | Research Administration | Manager | Supports funding, compliance, collaboration, and conference activity |
| 9 | Congress / Event Marketing Manager | Marketing / Events | Manager | Relevant for exhibitor services, sponsorship, and event operations vendors |
| 10 | Patient Advocacy Director / Program Manager | Advocacy / Community Engagement | Director / Manager | Influences patient education, outreach, and collaboration programs |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer base includes cancer centers, hospitals, and care networks | Clinical services, procurement, diagnostics, and care delivery solutions |
| 2 | Pharmaceuticals | Major presence of drug developers and medical affairs teams | Congress support, scientific services, oncology drug marketing |
| 3 | Biotechnology | Strong translational and biomarker research relevance | Discovery tools, assay platforms, partnerships, and innovation scouting |
| 4 | Research | Scientific meeting centered on research breakthroughs | Research software, publications, lab tools, and consulting |
| 5 | Medical Devices | Relevant for oncology diagnostics, imaging, and treatment-support products | Device commercialization, KOL engagement, and clinical evidence support |
| 6 | Information Technology & Services | Research workflows, data management, and digital collaboration are central to the event | Clinical data, AI, analytics, and secure collaboration platforms |
| 7 | Medical Practice | Physician attendees are a key audience segment | Continuing education, clinical decision support, and patient management tools |
| 8 | Government Administration | Public health, research funding, and policy stakeholders may participate | Public-sector partnerships, grants, and educational programs |
| 9 | Nonprofit Organization Management | Patient advocacy and research nonprofit participation is explicitly referenced | Fundraising, patient support, and education partnerships |
| 10 | Events Services | Exhibitions, affiliate meetings, satellite symposia, and support opportunities | Sponsorship, exhibitor services, logistics, AV, and registration solutions |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 11,000+ | Confirmed | Official SABCS website homepage | Organizer-stated attendance figure |
| Exhibitor count | More than 100 organizations | Confirmed | Official SABCS website homepage | Includes industry and nonprofit organizations |
| Buyer count | Not publicly confirmed by the organizer | Unavailable | No official buyer list published in the provided source content | Buyer mix inferred from event description |
| Speaker count | Not publicly confirmed by the organizer | Unavailable | Agenda referenced on the official website, but no count provided in source text | Do not infer a count without official data |
| Sponsor count | Not publicly confirmed by the organizer | Unavailable | Support opportunities are listed, but no count provided | Use sponsor prospecting lists separately if available |
| Historical attendance | 11,000+ attendees; 104 countries | Confirmed historical / current organizer claim | Official SABCS website homepage | Useful for audience scale and outreach planning |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical research | Trial execution, protocol management, site support | Connect with trial leaders, research administrators, and sponsor teams | CRO services, eClinical tools, patient recruitment, CTMS |
| Oncology diagnostics | More precise testing, faster interpretation, biomarker support | Target pathology and lab decision-makers | Assays, imaging, molecular diagnostics, lab automation |
| Medical affairs | Scientific exchange and external education | Engage pharma leaders around congress strategy and evidence needs | Congress support, advisory boards, medical communications |
| Research technology | Data capture, analytics, secure collaboration | Position workflow and analytics improvements to research teams | LIMS, AI analytics, secure portals, data integration |
| Patient advocacy and education | Support tools, educational resources, community programs | Partner with nonprofits and advocacy leaders | Education platforms, patient engagement, fundraising support |
| Event activation | Exhibit management, sponsorship ROI, attendee engagement | Sell services to exhibiting organizations and sponsors | Booth design, lead capture, registration, AV, logistics |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The attendee base includes researchers, clinicians, healthcare leaders, and pharma stakeholders with active buying influence. |
| Decision-maker availability | High | Conference structure and exhibit/symposium programming make senior stakeholders accessible. |
| Data collection potential | High | Useful for attendee list building, sponsor prospecting, and oncology account research. |
| Apollo targeting potential | Very High | Strong alignment with hospital, pharma, biotech, research, and medical affairs filters. |
| Geographic targeting potential | Very High | Global event with clear U.S. and international segmentation opportunities. |
| Best outreach approach | Thought-leadership and account-based outreach | Lead with scientific relevance, clinical value, and partnership outcomes rather than generic promotion. |
| Overall lead quality | Very High | Excellent event for high-value healthcare, research, and life sciences lead generation. |
| Best use case | B2B attendee list building, oncology account targeting, sponsorship sales, and partnership sourcing | Best suited to suppliers selling into healthcare, research, diagnostics, pharma, and event services. |
| Limitations / risks | Moderate | Official current-year attendee names are not publicly provided in the source excerpt, so attendee-level confirmation is limited. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Research; Medical Devices; Information Technology & Services; Medical Practice; Nonprofit Organization Management; Government Administration; Events Services | Covers the highest-relevance attendee and buyer ecosystem for SABCS |
| Departments | Procurement, Research, Clinical Operations, Medical Affairs, R&D, Lab, Marketing, Events, Partnerships | Targets both buying centers and congress influence owners |
| Seniority | Manager, Director, VP, C-level, Partner/Principal | Prioritizes decision-makers and budget holders |
| Job titles | Procurement Director, Strategic Sourcing Manager, Clinical Trial Manager, Research Director, Medical Affairs Director, Oncology Program Director, Lab Director, Congress Manager, Partnerships Director | Aligns with event purchasing influence and attendance patterns |
| Geography | United States; Canada; United Kingdom; Germany; France; Netherlands; Switzerland; Spain; Italy; Japan; Australia; Singapore | Reflects the event’s international oncology audience and key life sciences markets |
| Employee size | 51–200, 201–500, 501–1,000, 1,001–5,000, 5,001–10,000, 10,000+ | Covers both specialist organizations and large enterprise buyers |
| Keywords | breast cancer, oncology, clinical research, translational research, medical affairs, cancer center, trial operations, biomarker, diagnostics, congress, symposium | Improves precision for event-relevant account discovery |
| Company type | Public companies, academic medical centers, nonprofit health systems, research institutes, pharma sponsors | Matches the core SABCS ecosystem |
Suggested Apollo Search Logic:
(oncology OR “breast cancer” OR “clinical research” OR “medical affairs” OR “cancer center”) AND
(procurement OR sourcing OR research OR “clinical operations” OR “lab director” OR “partnerships” OR “congress”)
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| San Antonio Breast Cancer Symposium official website | Official organizer website | Event name, date range, location, attendee scale, international reach, audience composition, exhibition/support opportunities | Very High |
| SABCS Symposium Overview | Official program / overview page | Event purpose, audience types, research scope, attendee mix | Very High |
| SABCS Meeting News | Official news / announcements page | Current-year announcements, abstracts, affiliate meetings, satellite symposium opportunities | High |
| SABCS Hotels page | Official attendee logistics page | Meeting city logistics and proximity to convention-center-related activities | High |
| SABCS Exhibition and Support Opportunities | Official sponsorship/exhibitor page | Exhibition relevance, sponsor participation context, industry/nonprofit attendance | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to San Antonio Breast Cancer Symposium - SABCS — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds